These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10476941)

  • 21. [New strategies for tumor-related cachexia].
    HNO; 1997 Nov; 45(11 Suppl):1-8. PubMed ID: 9509016
    [No Abstract]   [Full Text] [Related]  

  • 22. University of Miami Division of Clinical Pharmacology Therapeutic Rounds: medications used to treat anorexia in the frail elderly.
    Golden AG; Daiello LA; Silverman MA; Llorente M; Preston RA
    Am J Ther; 2003; 10(4):292-8. PubMed ID: 12845394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supportive treatment in weight-losing cancer patients due to the additive adverse effects of radiation treatment and/or chemotherapy.
    Erkurt E; Erkisi M; Tunali C
    J Exp Clin Cancer Res; 2000 Dec; 19(4):431-9. PubMed ID: 11277319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medroxyprogesterone and palliative care: new indication. No impact on quality of life.
    Prescrire Int; 2001 Feb; 10(51):3-4. PubMed ID: 11503858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anorexia and megestrol acetate: treatment versus placebo controlled study.
    Fernández-Lucas M; Díaz-Domínguez ME; Ruiz-Roso G; Raoch V; Teruel-Briones JL; Quereda-Rodríguez-Navarro C
    Nefrologia; 2014 May; 34(3):416-7. PubMed ID: 24849061
    [No Abstract]   [Full Text] [Related]  

  • 28. Low dose oral alpha-interferon therapy for patients seropositive for human immunodeficiency virus type-1 (HIV-1).
    Koech DK; Obel AO; Minowada J; Hutchinson VA; Cummins JM
    Mol Biother; 1990 Jun; 2(2):91-5. PubMed ID: 1973045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supportive role of a micronutrient appetite normaliser in convalescing patients.
    Madan ZM
    J Indian Med Assoc; 2001 Mar; 99(3):158-9. PubMed ID: 11478762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anorexia associated with bronchial cancer].
    Jeanfaivre T; Tuchais E
    Rev Mal Respir; 1997 Apr; 14(2):113-7. PubMed ID: 9198833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of human leukocyte interferon in patients with advanced cancer.
    Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA
    J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy of mirtazapine for appetite loss and nausea of the cancer patient--from clinical experience in Memorial Sloan-Kettering Cancer Center].
    Ito T; Okubo Y; Roth A
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):623-6. PubMed ID: 19381036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoids in the treatment of symptoms in cancer and AIDS #93.
    Wilner LS; Arnold RM
    J Palliat Med; 2006 Jun; 9(3):802-4. PubMed ID: 16752986
    [No Abstract]   [Full Text] [Related]  

  • 34. A phase I clinical tolerance study of rDNA alpha 2 human interferon in patients with non-reticuloendothelial system malignancies.
    Edelstein MB; Schellekens H; Laurent T; Gauci L
    Eur J Cancer Clin Oncol; 1983 Jul; 19(7):891-4. PubMed ID: 6350014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oromucosal Administration of Interferon to Humans.
    Beilharz MW; Cummins MJ; Bennett AL; Cummins JM
    Pharmaceuticals (Basel); 2010 Jan; 3(2):323-344. PubMed ID: 27713254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of Cucumber mosaic virus as a vector modifiable for different host species to produce therapeutic proteins.
    Matsuo K; Hong JS; Tabayashi N; Ito A; Masuta C; Matsumura T
    Planta; 2007 Jan; 225(2):277-86. PubMed ID: 16821041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anorexia in cancer: role of feeding-regulatory peptides.
    Perboni S; Inui A
    Philos Trans R Soc Lond B Biol Sci; 2006 Jul; 361(1471):1281-9. PubMed ID: 16815804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose oral use of human interferon-alpha in cancer patients.
    Cummins MJ; Pruitt B
    J Interferon Cytokine Res; 1999 Aug; 19(8):937-41. PubMed ID: 10476941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group.
    ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T
    J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group.
    Jatoi A; Dakhil SR; Nguyen PL; Sloan JA; Kugler JW; Rowland KM; Soori GS; Wender DB; Fitch TR; Novotny PJ; Loprinzi CL
    Cancer; 2007 Sep; 110(6):1396-403. PubMed ID: 17674351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.